In an adult presenting with a movement disorder, how should I classify it as hyperkinetic or hypokinetic, define the specific phenotype, and initiate appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Movement Disorders in Adults: Classification, Definition, and Management

Initial Classification: Hypokinetic vs. Hyperkinetic

Begin by categorizing the movement disorder as either hypokinetic (reduced movement) or hyperkinetic (excessive movement), as this fundamental distinction drives all subsequent diagnostic and therapeutic decisions. 1, 2

Hypokinetic Disorders (Parkinsonian Syndromes)

  • Characterized by bradykinesia plus either rigidity or resting tremor 3
  • Test for bradykinesia by observing finger tapping, hand opening/closing, and rapid alternating movements 3
  • Check for rigidity by passively moving limbs while the patient relaxes, noting any cogwheel phenomenon 3
  • Include idiopathic Parkinson's disease and atypical parkinsonian syndromes 1

Hyperkinetic Disorders

  • Encompass chorea, ballism, tremor, dystonia, myoclonus, and tics 4, 5
  • Most acute presentations are hyperkinetic, though some are mixed 2
  • Caused by disturbances in circuitry connecting cerebral cortex, thalamus, basal ganglia, and cerebellum 4

Specific Hyperkinetic Phenotypes: Definitions and Key Features

Dystonia

  • Sustained or intermittent muscle contractions causing abnormal postures 5
  • May be focal, segmental, or generalized based on body distribution 6
  • Deep brain stimulation has a well-defined role in medically refractory cases 6

Chorea

  • Irregular, flowing, dance-like involuntary movements 4, 5
  • Includes Huntington disease as prototypical example 1
  • Symptomatic pharmacological treatment remains the mainstay 6

Tremor

  • Rhythmic oscillatory movements 5
  • Can be resting (Parkinson's), action (essential tremor), or postural 3
  • Internal tremor sensations may precede visible tremor in Parkinson's disease 3

Myoclonus

  • Sudden, brief, shock-like jerks 5
  • Address prejerk cognitions including anxiety, frustration, and breath-holding 7
  • Diaphragmatic breathing and progressive muscular relaxation can be beneficial 7

Tics

  • Very brief jerks or dystonic postures, typically shorter than paroxysmal dyskinesia attacks 1
  • Cardinal features of Tourette syndrome 6
  • Pimozide is superior to haloperidol in efficacy and side effects for tic control 7

Ballism

  • Large-amplitude, flinging movements typically affecting proximal limbs 4

Paroxysmal Movement Disorders: Critical Distinctions

Paroxysmal Kinesigenic Dyskinesia (PKD)

  • Triggered by sudden voluntary actions (standing, starting to run, getting on/off a car) 1
  • Attacks last seconds to minutes, consciousness preserved 1
  • Carbamazepine 50-200 mg/day achieves complete remission in >85% of patients 7
  • Start at 50 mg (or 1 mg/kg in children), titrate based on response 7
  • Screen for HLA-B*15:02 in Han Chinese populations before initiating carbamazepine to reduce Stevens-Johnson syndrome risk 7
  • Oxcarbazepine 75-300 mg/day is an alternative option 7

Paroxysmal Nonkinesigenic Dyskinesia (PNKD)

  • Triggered by nonkinesigenic factors: tea, coffee, alcohol, psychological stress, fatigue 1
  • Attacks last 10 minutes to 1 hour, longer than PKD 1
  • Lower attack frequency than PKD 1

Paroxysmal Exercise-Induced Dyskinesia (PED)

  • Induced by prolonged or continuous exercise (5-30 minutes) 1
  • Not triggered by nonkinesigenic factors like cold, alcohol, or coffee 1
  • Duration ranges 5-45 minutes, typically not exceeding 2 hours 1

Differential Diagnosis: Critical Distinctions

PKD vs. Frontal Lobe Epilepsy

  • PKD has clear kinesigenic trigger and preserved consciousness during attacks 1
  • Frontal lobe epilepsy may have slight consciousness disturbance and can occur during sleep 1
  • PKD only occurs when patients are awake 1

Functional (Psychogenic) Movement Disorders

  • Red flags: distractibility, variability between paroxysms, suggestibility 1
  • Adult age of onset, altered responsiveness during attacks, medically unexplained somatic symptoms 1
  • Atypical response to medications 1
  • Video recording interventions demonstrates symptom changeability and highlights successes 7

Management Algorithm

Step 1: Identify and Address Reversible Causes

Always check serum calcium first, as hypocalcemia can induce or worsen any movement disorder 3

  • Obtain parathyroid hormone if calcium is low 3
  • Check magnesium levels, as hypomagnesemia frequently coexists with hypocalcemia 3
  • Measure TSH to exclude thyroid dysfunction 3
  • Check glucose in diabetic patients, as hypoglycemia produces tremor sensations 3

Step 2: Medication Review

Drugs are a common cause of movement disorders 4

  • Primary intervention is discontinuation or dose reduction of the offending agent when clinically feasible 8
  • Switch to lower-risk agents (quetiapine or clozapine for antipsychotics) when complete discontinuation is not possible 8
  • Drug-induced tremor usually resolves after discontinuation 3
  • Distinguish drug-induced effects from disease progression by decreasing dose or stopping medication 7

Step 3: Drug-Induced Parkinsonism Management

For drug-induced parkinsonism and acute dystonia, initiate benztropine 1-4 mg once or twice daily 8

  • Most effective for tremor and rigidity components 8
  • Avoid benztropine in elderly patients with Alzheimer's disease or dementia due to anticholinergic cognitive side effects 8
  • Use anticholinergic medications with caution in elderly patients 8

Step 4: Specific Hyperkinetic Disorder Management

Dystonia

  • Encourage optimal postural alignment with even weight distribution in sitting, standing, and walking 7
  • Grade activities to increase affected limb use with normal movement techniques 7
  • Avoid end-range joint positioning (full hip, knee, or ankle flexion while sitting) 7
  • Support the affected limb at rest using pillows or furniture to reduce overactivity, pain, and fatigue 7
  • Address pain and hypersensitivity as associated problems 7
  • Do not discourage splinting, as it may prevent restoration of normal movement and potentially trigger complex regional pain syndrome 7

Functional Tremor

  • Superimpose alternative voluntary rhythms on existing tremor, gradually slowing to complete rest 7
  • Use the unaffected limb to dictate a new rhythm (tapping or opening/closing the hand) to entrain tremor to stillness 7
  • Assist muscle relaxation to prevent cocontraction 7
  • Use gross rather than fine movements (large marker on whiteboard versus normal handwriting) 7
  • Discourage cocontraction or tensing as a tremor suppression method 7

Functional Jerks/Myoclonus

  • Address prejerk cognitions: anxiety, frustration, and breath-holding 7
  • Implement diaphragmatic breathing and progressive muscular relaxation 7
  • Use sensory grounding techniques: noticing environmental details, feeling textured items, cognitive distractors 7
  • Encourage slow movement activities (yoga or tai chi) to regain movement control and redirect attention 7

Tourette Syndrome/Tic Disorders

  • Pimozide is superior to haloperidol in efficacy and side effects for tic control 7
  • Both pimozide and haloperidol are FDA-approved 7
  • Deep brain stimulation of CM-Pf thalamus, GPi, or NAc shows substantial improvement in approximately 97% of severe, treatment-refractory cases 7
  • DBS should only be considered after failure of standard pharmacological and behavioral therapies in severe cases with significant impact on daily functioning 7

Step 5: Monitoring and Re-evaluation

  • Regular monitoring using standardized scales like the Abnormal Involuntary Movement Scale (AIMS) every 3-6 months 8
  • Periodically re-evaluate treatment necessity by assessing chorea effect versus adverse effects 7
  • Correct metabolic abnormalities before attributing symptoms to disease progression or psychiatric causes 3

Critical Clinical Pitfalls

  • If anticholinergic medication is added during initial antipsychotic treatment, maintain it well after antipsychotic discontinuation to prevent delayed emergence of symptoms 8
  • In psychiatric patients requiring antipsychotics, carefully balance the risk of psychotic relapse against the severity of parkinsonian symptoms 8
  • Propranolol is first-line for essential tremor but has no established role in managing drug-induced movement disorders 8
  • Anxiety management and distraction techniques are helpful across all hyperkinetic symptom types 7
  • Refer to movement disorders neurology if diagnostic uncertainty exists about whether symptoms represent early Parkinson's disease, atypical parkinsonism, or another condition 3

Imaging Considerations

MRI is preferred over CT for initial structural imaging assessment 1

  • Look for patterns of atrophy, parenchymal abnormality, or abnormal substance deposition 1
  • Exclude underlying structural or vascular lesions, autoimmune or infectious processes, drug toxicity, or hydrocephalus 1
  • Nuclear medicine studies can evaluate abnormal glucose metabolism patterns, buildup of abnormal proteins, or neurochemical deficits 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Emergency presentations of movement disorders.

Practical neurology, 2020

Guideline

Internal Tremors: Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

6: Movement disorders II: the hyperkinetic disorders.

The Medical journal of Australia, 2001

Research

The clinical approach to movement disorders.

Nature reviews. Neurology, 2010

Research

What is new in tics, dystonia and chorea?

Clinical medicine (London, England), 2016

Guideline

Treatment of Hyperkinetic Movement Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Medication-Induced Movement Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.